azides has been researched along with mitotane in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bates, SE; Dichek, HL; Fojo, AT; Gazdar, A; Loriaux, DL; Mickley, LA; Shieh, CY | 1 |
| Belani, CP; Gutheil, JC; Hart, SR; Hussain, A; Melera, PW | 1 |
2 other study(ies) available for azides and mitotane
| Article | Year |
|---|---|
Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (mdr-1/P-glycoprotein) which is also expressed by adrenocortical carcinomas.
Topics: Adrenal Cortex Neoplasms; Affinity Labels; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Survival; Dactinomycin; Dihydropyridines; Drug Resistance; Gene Expression; Humans; Membrane Glycoproteins; Mitotane; Nucleic Acid Hybridization; RNA, Messenger; Tumor Cells, Cultured; Vinblastine | 1991 |
Alterations in Ca2+ transport ATPase and P-glycoprotein expression can mediate resistance to thapsigargin.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Calcium-Transporting ATPases; Carrier Proteins; Cell Division; Cell Line; Cell Survival; Colchicine; Cricetinae; Cricetulus; Dactinomycin; Daunorubicin; Dihydropyridines; DNA, Complementary; Drug Resistance; Gene Expression; Lung; Membrane Glycoproteins; Mitotane; Multigene Family; Substrate Specificity; Terpenes; Thapsigargin; Transfection; Vincristine | 1994 |